Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interferon beta for secondary progressive multiple sclerosis.
Novantrone (mitoxantrone HCl) Injection February 2009
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
A much-needed focus on progression in multiple sclerosis.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study.
Interferon β for secondary progressive multiple sclerosis: a systematic review.
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Gordon Research Conference on Immunochemistry & Immunobiology
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study.
Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis.
No Differences Observed among Multiple Clinical S1P1 Receptor Agonists (Functional Antagonists) in S1P1 Receptor Down-regulation and Degradation.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients.
Study of teriflunomide in reducing the frequency of relapses and accumulation of disability in patients with multiple sclerosis (TEMSO)
Pericytes are required for blood-brain barrier integrity during embryogenesis.
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months

Pages